Human B7-1 is more efficient than B7-2 in providing co-stimulation for alloantigen-specific T cells
- 1 September 1996
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 26 (9) , 2275-2278
- https://doi.org/10.1002/eji.1830260946
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitroInternational Immunology, 1995
- B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4Immunity, 1995
- CD28/CTLA-4 receptor structure, binding stoichiometry and aggregation during T-cell activationResearch in Immunology, 1995
- CTLA4 mediates antigen-specific apoptosis of human T cells.Proceedings of the National Academy of Sciences, 1995
- Leukemia‐associated changes identified by quantitative flow cytometry: I. CD10 expressionCytometry, 1994
- Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.The Journal of Experimental Medicine, 1994
- Functional characterization of a novel anti‐B7 monoclonal antibodyEuropean Journal of Immunology, 1992
- Limiting dilution assaysJournal of Immunological Methods, 1987